Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 7951 - 7975 of 10644 in total

Ozuriftamab vedotin

Investigational

Nisevokitug

Nisevokitug is a monoclonal antibody targeted against transforming growth factor beta (TGFβ) under investigation in NCT04097821 (A Randomized, Open-label, Phase I/II Open Platform Study Evaluating Safety and Efficacy of Novel Ruxolitinib Combinations in Myelofibrosis Patients).
Investigational

Ivaltinostat

Investigational

Iproniazid

Withdrawn from the Canadian market in July 1964 due to interactions with food products containing tyrosine.
Withdrawn
Matched Iupac: … N'-(propan-2-yl)pyridine-4-carbohydrazide …

Pyridoxyl-Glutamic Acid-5'-Monophosphate

Experimental
Matched Iupac: … 4-({[(1S)-1,3-dicarboxypropyl]amino}methyl)-3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-1-ium …

Bis(5-Amidino-2-Benzimidazolyl)Methanone

Experimental

11-[(MERCAPTOCARBONYL)OXY]UNDECANOIC ACID

Experimental

2'-fluoro-2'-deoxyuridine 3'-monophosphate

Experimental
Matched Iupac: … {[(2R,3R,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-4-fluoro-2-(hydroxymethyl)oxolan-3-yl] …

BMSC-0013

Experimental

Succinylated gelatin

Experimental

DR-01

DR-01 is a monoclonal antibody directed against human CD94.
Investigational

Nesolicaftor

Nesolicaftor (PTI-428) is under investigation in clinical trial NCT03258424 (Study Assessing PTI-428 Safety, Tolerability, and Pharmacokinetics in Subjects With Cystic Fibrosis on KALYDECO® as Background Therapy).
Investigational

9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine

Experimental

6-Chloropurine Riboside, 5'-Monophosphate

Experimental

5-Formyl-2'-deoxy-cytidine-5'-monophosphate

Experimental
Matched Iupac: … {[(2R,3S,5R)-5-(4-amino-5-formyl-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methoxy}phosphonic …

1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE

Experimental

Deacetylbisacodyl

Experimental
Matched Iupac: … 4-[(4-hydroxyphenyl)(pyridin-2-yl)methyl]phenol …

Socazolimab

Socazolimab is under investigation in clinical trial NCT04878016 (A Study of Carboplatin Plus Etoposide With or Without ZKAB001 (Anti-pd-l1 Antibody) in Patients With ES-SCLC).
Investigational

{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid

Experimental

(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE

Experimental

9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine

Experimental

3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate

Experimental

N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE

Experimental

PVX-410 component XBP1 US184-192(YISPWILAV)

Investigational

Humanized monoclonal antibody Hu11E6

Investigational
Displaying drugs 7951 - 7975 of 10644 in total